Phase II Trial of Temsirolimus (CCI-779) in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study
作者： Evanthia Galanis , Jan C. Buckner , Matthew J. Maurer , Jeffrey I. Kreisberg , Karla Ballman
关键词:
摘要: Background Temsirolimus (CCI-779) is a small-molecule inhibitor of the mammalian target of rapamycin (mTOR) and represents a rational therapeutic target against glioblastoma …
elsevier.com
jco.org参考文章(32)
Stephen B. Tatter, Recurrent malignant glioma in adults. Current Treatment Options in Oncology. ,vol. 3, pp. 509- 524 ,(2002) , 10.1007/S11864-002-0070-8
Gregory J. Brunn, Christine C. Hudson, Aleksandar Sekulić, Josie M. Williams, Hajime Hosoi, Peter J. Houghton, John C. Lawrence, Robert T. Abraham, Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin Science. ,vol. 277, pp. 99- 101 ,(1997) , 10.1126/SCIENCE.277.5322.99
Jeffrey I. Kreisberg, Shazli N. Malik, Thomas J. Prihoda, Roble G. Bedolla, Dean A. Troyer, Suzanne Kreisberg, Paramita M. Ghosh, Phosphorylation of Akt (Ser473) is an Excellent Predictor of Poor Clinical Outcome in Prostate Cancer Cancer Research. ,vol. 64, pp. 5232- 5236 ,(2004) , 10.1158/0008-5472.CAN-04-0272
Michael B. Atkins, Manuel Hidalgo, Walter M. Stadler, Theodore F. Logan, Janice P. Dutcher, Gary R. Hudes, Young Park, Song-Heng Liou, Bonnie Marshall, Joseph P. Boni, Gary Dukart, Matthew L. Sherman, Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma. Journal of Clinical Oncology. ,vol. 22, pp. 909- 918 ,(2004) , 10.1200/JCO.2004.08.185
M. S. Neshat, I. K. Mellinghoff, C. Tran, B. Stiles, G. Thomas, R. Petersen, P. Frost, J. J. Gibbons, H. Wu, C. L. Sawyers, Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR Proceedings of the National Academy of Sciences of the United States of America. ,vol. 98, pp. 10314- 10319 ,(2001) , 10.1073/PNAS.171076798
A.-C. Gingras, S. G. Kennedy, M. A. O'Leary, N. Sonenberg, N. Hay, 4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway Genes & Development. ,vol. 12, pp. 502- 513 ,(1998) , 10.1101/GAD.12.4.502
Thomas Prihoda, Michael Brattain, Jeffrey I. Kreisberg, Roble Bedolla, Dean A. Troyer, Shazli N. Malik, Paramita M. Ghosh, Immunohistochemical Demonstration of Phospho-Akt in High Gleason Grade Prostate Cancer Clinical Cancer Research. ,vol. 8, pp. 1168- 1171 ,(2002)
Arnab Chakravarti, Gary Zhai, Yoshiyuki Suzuki, Sormeh Sarkesh, Peter M. Black, Alona Muzikansky, Jay S. Loeffler, The Prognostic Significance of Phosphatidylinositol 3-Kinase Pathway Activation in Human Gliomas Journal of Clinical Oncology. ,vol. 22, pp. 1926- 1933 ,(2004) , 10.1200/JCO.2004.07.193
Alba Ariela Brandes, Mario V. Fiorentino, The Role of Chemotherapy in Recurrent Malignant Gliomas: An Overview Cancer Investigation. ,vol. 14, pp. 551- 559 ,(1996) , 10.3109/07357909609076900
Edward A. Sausville, Susan G. Arbuck, Melinda Hollingshead, Peter J. Houghton, Pamela J. Cheshire, Michael B. Dilling, Franklin C. Harwood, Lorina Dudkin, Robert Travis, Biochemical Correlates of mTOR Inhibition by the Rapamycin Ester CCI-779 and Tumor Growth Inhibition Clinical Cancer Research. ,vol. 7, pp. 1758- 1764 ,(2001)